Lipocine Inc reports results for the quarter ended in December - Earnings Summary

Lipocine

10/03/2023 14:01

* Lipocine Inc  LPCN.OQ  reported a quarterly adjusted loss
of 3
cents​​ per share for the quarter ended in December. The mean
expectation of three analysts for the quarter was for a loss
of 3 cents per share.
    * Reported revenue was zero​; analysts expected $1.31
million. 
    * Lipocine Inc's reported EPS for the quarter was a loss
of 3
cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Lipocine Inc shares had risen by 5.6% this quarter.
    * The company reported a quarterly loss of $2.23 million.
    * Wall Street's median 12-month price target for Lipocine
Inc is
$4.00 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
March 10 at 02:01 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      -0.03          -0.03          Met
 Sep. 30 2022      -0.03          -0.03          Met
 Jun. 30 2022      -0.04          -0.03          Beat
 Mar. 31 2022      -0.02          -0.04          Missed